4 research outputs found
Nitazoxanide Cocrystals in Combination with Succinic, Glutaric, and 2,5-Dihydroxybenzoic Acid
Combination of nitazoxanide (NTZ)
with a total of 32 cocrystal
formers gave cocrystals with succinic acid (NTZ-SUC, 2:1) and glutaric
acid (NTZ-GLU, 1:1). Additionally, 2,5-dihydroxybenzoic acid provided
a cocrystal solvate with acetonitrile (NTZ-25DHBA-CH<sub>3</sub>CN,
1:1:1). All solid phases were characterized by X-ray powder diffraction
analysis, IR spectroscopy, thermogravimetric analysis, differential
scanning calorimetry, and single-crystal X-ray diffraction analysis.
Single-crystal X-ray crystallography revealed that NTZ and the carboxylic
acid cocrystal formers were linked in all three cocrystals through
the same supramolecular heterodimeric synthon, C(N)NH···HOOC.
Despite having different stoichiometries, the crystal structures of
NTZ-SUC and NTZ-GLU showed similarities in the supramolecular organization,
both containing two-dimensional layers formed by NTZ molecules, which
were further interconnected by single (NTZ-SUC) and homodimeric entities
(NTZ-GLU) of the cocrystal former. Basic physical stability tests
showed that cocrystals NTZ-SUC and NTZ-GLU are stable at least for
one month under standardized temperature/relative humidity stress
conditions but decompose within 1 h into the corresponding physical
phase mixtures, when exposed to aqueous solutions simulating physiological
gastrointestinal conditions. Measurement of the dissolution rates
gave small increases of the intrinsic dissolution rate constants when
compared with NTZ. Pressure stability tests showed that the cocrystals
support higher pressures (at least up to 60 kg/cm<sup>2</sup>) than
NTZ
Nitazoxanide Cocrystals in Combination with Succinic, Glutaric, and 2,5-Dihydroxybenzoic Acid
Combination of nitazoxanide (NTZ)
with a total of 32 cocrystal
formers gave cocrystals with succinic acid (NTZ-SUC, 2:1) and glutaric
acid (NTZ-GLU, 1:1). Additionally, 2,5-dihydroxybenzoic acid provided
a cocrystal solvate with acetonitrile (NTZ-25DHBA-CH<sub>3</sub>CN,
1:1:1). All solid phases were characterized by X-ray powder diffraction
analysis, IR spectroscopy, thermogravimetric analysis, differential
scanning calorimetry, and single-crystal X-ray diffraction analysis.
Single-crystal X-ray crystallography revealed that NTZ and the carboxylic
acid cocrystal formers were linked in all three cocrystals through
the same supramolecular heterodimeric synthon, C(N)NH···HOOC.
Despite having different stoichiometries, the crystal structures of
NTZ-SUC and NTZ-GLU showed similarities in the supramolecular organization,
both containing two-dimensional layers formed by NTZ molecules, which
were further interconnected by single (NTZ-SUC) and homodimeric entities
(NTZ-GLU) of the cocrystal former. Basic physical stability tests
showed that cocrystals NTZ-SUC and NTZ-GLU are stable at least for
one month under standardized temperature/relative humidity stress
conditions but decompose within 1 h into the corresponding physical
phase mixtures, when exposed to aqueous solutions simulating physiological
gastrointestinal conditions. Measurement of the dissolution rates
gave small increases of the intrinsic dissolution rate constants when
compared with NTZ. Pressure stability tests showed that the cocrystals
support higher pressures (at least up to 60 kg/cm<sup>2</sup>) than
NTZ
A Twist in Cocrystals of Salts: Changes in Packing and Chloride Coordination Lead to Opposite Trends in the Biopharmaceutical Performance of Fluoroquinolone Hydrochloride Cocrystals
Fluoroquinolones are extensively
used antibiotics that are generally
prescribed as hydrochloride salts because the neutral forms display
low solubility due to their zwitterionic character. Starting from
the hydrochloride salts of ciprofloxacin (CiHCl) or (<i>S</i>,<i>S</i>)-moxifloxacin (MoHCl) and 4-hydroxybenzoic acid
(4HBA) as a cocrystal former, two cocrystalline solids, CiHCl–4HBA
and MoHCl–4HBA, were obtained in a salt/coformer stoichiometric
ratio of 1:1. The cocrystalline phases were identified by X-ray powder
diffraction analysis and further characterized by IR spectroscopy,
thermogravimetric analysis-differential scanning calorimetry, and
single crystal X-ray diffraction analysis. The novel solid phases
could be formed using different methodologies, namely, solution-mediated
phase transformation, solvent drop grinding, crystallization by solvent
evaporation, and reaction crystallization. Pharmaceutically relevant
properties such as phase stability, thermodynamic solubility, and
dissolution rate were examined. All cocrystalline phases remained
stable when suspended in acidic aqueous solutions and did not transform
upon accelerated temperature/relative humidity exposition for 30 days.
Interestingly, opposite trends in the thermal stability, solubility,
and dissolution rate of the cocrystals were exhibited by the different
fluoroquinolones in comparison to the parent starting salts. Upon
heating, the CiHCl–4HBA cocrystal releases first the coformer
before decomposing and displayed a lower solubility and dissolution
rate in comparison to CiHCl·1.34H<sub>2</sub>O. By contrast,
the MoHCl–4HBA cocrystal melts in a single-phase transition
process and showed enhanced solubility and dissolution rate when compared
to the parent moxifloxacin salt. The similar composition of the cocrystals
and the structural resemblance of the fluoroquinolones examined herein
allowed for a detailed vis-à-vis comparison between the supramolecular
structures in the solid-state and the physicochemical properties.
The incorporation of 4HBA in the crystal lattice caused changes in
the number, type, and strength of the intermolecular interactions
between the ionic components (chloride and fluoroquinolinium cations),
which could be related to the solubility and dissolution rate properties.
While the cocrystal CiHCl–4HBA retained essential features
of the supramolecular assembly found also for the starting hydrochloride
and gave an overall three-dimensional hydrogen bonded network with
the cocrystal former, MoHCl–4HBA showed a singular two-dimensional
assembly, with linear chains formed between the 4HBA molecules and
chloride ions through O–H···Cl<sup>–</sup>···H–O hydrogen bonds in place of the usual
charged-assisted N<sup>+</sup>–H···Cl<sup>–</sup> interactions
Cocrystals of Active Pharmaceutical IngredientsPraziquantel in Combination with Oxalic, Malonic, Succinic, Maleic, Fumaric, Glutaric, Adipic, And Pimelic Acids
The
combination of racemic praziquantel, (<i>RS</i>)-PZQ,
with aliphatic dicarboxylic acids of the homologous series HOOC–(CH<sub>2</sub>)<sub><i>n</i></sub>–COOH (with <i>n</i> = 0–8) and the unsaturated analogues of succinic acid as
cocrystal formers via liquid-assisted grinding provided a total of
nine 1:1 and 2:1 cocrystals with oxalic acid, malonic acid, succinic
acid (two polymorphic phases), maleic acid, fumaric acid, glutaric
acid, adipic acid, and pimelic acid. The cocrystalline phases were
identified first by XRPD analysis and then structurally characterized
by IR spectroscopy and, as far as possible, by single-crystal X-ray
diffraction analysis. Crystals suitable for XRD analysis were obtained
for seven cocrystals and, additionally, for (<i>RS</i>)-PZQ.
The analysis of the supramolecular interactions in the crystal structures
has shown that the dominant hydrogen bonding patterns within the cocrystals
are heterodimeric motifs formed through O–H···O
hydrogen bonds between PZQ and the dicarboxylic acids, which mostly
contain additionally at least one secondary C–H···O
contact. In all crystal structures, the PZQ molecules are connected
with each other through cyclic homodimeric hydrogen bonding interactions
formed mainly through C–H···O, but also through
C–H···π contacts, giving overall 1D, 2D or 3D hydrogen bonded networks. The crystallographic study also allowed
us to establish that there are two main rotational conformers for
PZQ, which differ in the configuration of the CO groups in
the piperazinone–cyclohexylcarbonyl segment. In the crystal
structure of (<i>RS</i>)-PZQ, all four independent molecules
in the asymmetric unit have the <i>syn</i>-conformation,
which in the hemihydrates, viz. (<i>R</i>)-PZQ·0.5H<sub>2</sub>O and (<i>S</i>)-PZQ·0.5H<sub>2</sub>O, and
all cocrystals except for one are switched to the <i>anti</i>-antagonist